Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Amphastar Pharmaceuticals, Inc. | amph-20151231x10k.htm |
| EX-32.2 - EX-32.2 - Amphastar Pharmaceuticals, Inc. | amph-20151231ex322a640d8.htm |
| EX-32.1 - EX-32.1 - Amphastar Pharmaceuticals, Inc. | amph-20151231ex32169fc1a.htm |
| EX-10.28 - EX-10.28 - Amphastar Pharmaceuticals, Inc. | amph-20151231ex102850289.htm |
| EX-21.1 - EX-21.1 - Amphastar Pharmaceuticals, Inc. | amph-20151231ex21167e953.htm |
| EX-31.1 - EX-31.1 - Amphastar Pharmaceuticals, Inc. | amph-20151231ex3115a742f.htm |
| EX-31.2 - EX-31.2 - Amphastar Pharmaceuticals, Inc. | amph-20151231ex3122877f5.htm |
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
(1) |
Registration Statement (Form S-8 No. 333-197054) pertaining to the 1999-2002 Stock Option/Stock Issuance Plans, the Amended and Restated 2005 Equity Incentive Award Plan and the 2014 Employee Stock Purchase Plan of Amphastar Pharmaceuticals, Inc. |
|
(2) |
Registration Statement (Form S-8 No. 333-203017) pertaining to the Amended and Restated 2005 Equity Incentive Award Plan of Amphastar Pharmaceuticals, Inc. |
|
(3) |
Registration Statement (Form S-3 No. 333-205459) of Amphastar Pharmaceuticals, Inc. |
|
(4) |
Registration Statement (Form S-8 No. 333-205470) pertaining to the 2015 Equity Incentive Plan of Amphastar Pharmaceuticals, Inc. |
of our report dated March 15, 2016, with respect to the consolidated financial statements of Amphastar Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of Amphastar Pharmaceuticals, Inc. for the year ended December 31, 2015.
/s/ Ernst & Young LLP
Los Angeles, California
March 15, 2016